Sanofi SA Company Profile (NYSE:SNY)

About Sanofi SA

Sanofi SA logoSanofi SA, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. It operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation. Its pharmaceuticals portfolio consists of products and a range of prescription medicines, generic medicines and consumer health products. The Vaccines segment is dedicated to vaccines, including research, development, production and marketing. The Animal Health segment includes the research, development, production and marketing activities of Merial, which offers a range of medicines and vaccines for a range of animal species. It operates in the Other segment, which includes the effects of retained commitments. It operates through Regeneron Pharmaceuticals Inc.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: SNY
  • CUSIP:
Key Metrics:
  • Previous Close: $43.13
  • 50 Day Moving Average: $41.40
  • 200 Day Moving Average: $39.85
  • 52-Week Range: $36.81 - $44.50
  • Trailing P/E Ratio: 22.63
  • Foreward P/E Ratio: 13.15
  • P/E Growth: 1.97
  • Market Cap: $112.10B
  • Outstanding Shares: 2,565,800,000
  • Beta: 0.98
Profitability:
  • Net Margins: 13.66%
  • Return on Equity: 26.37%
  • Return on Assets: 14.46%
Debt:
  • Debt-to-Equity Ratio: 0.27%
  • Current Ratio: 1.47%
  • Quick Ratio: 1.00%
Additional Links:
Companies Related to Sanofi SA:

Analyst Ratings

Consensus Ratings for Sanofi SA (NYSE:SNY) (?)
Ratings Breakdown: 1 Sell Rating, 6 Hold Ratings, 7 Buy Ratings
Consensus Rating:Hold (Score: 2.43)
Consensus Price Target: $75.50 (75.05% upside)

Analysts' Ratings History for Sanofi SA (NYSE:SNY)
Show:
DateFirmActionRatingPrice TargetDetails
2/9/2017NatixisUpgradeNeutral -> BuyView Rating Details
1/10/2017Leerink SwannReiterated RatingOutperformView Rating Details
1/8/2017Goldman Sachs Group IncReiterated RatingHoldView Rating Details
11/29/2016Morgan StanleyUpgradeEqual Weight -> OverweightView Rating Details
9/23/2016Piper Jaffray CompaniesInitiated CoverageNeutralView Rating Details
9/15/2016J P Morgan Chase & CoReiterated RatingUnderweightView Rating Details
9/14/2016Jefferies Group LLCReiterated RatingHoldView Rating Details
9/13/2016BNP ParibasUpgradeUnderperform -> NeutralView Rating Details
9/8/2016Berenberg BankUpgradeHold -> BuyView Rating Details
6/28/2016Citigroup Inc.Reiterated RatingNeutralView Rating Details
5/12/2016Barclays PLCUpgradeEqual Weight -> OverweightView Rating Details
5/3/2016HSBC Holdings plcDowngradeBuy -> HoldView Rating Details
5/3/2016Bank of America CorpReiterated RatingBuy$58.00View Rating Details
4/12/2016Chardan CapitalReiterated RatingBuyView Rating Details
2/10/2016Sanford C. BernsteinLower Price TargetMarket-Perform$52.00 -> $45.00View Rating Details
12/16/2015Oddo SecuritiesDowngradeReduceView Rating Details
11/9/2015Bryan, Garnier & CoReiterated RatingBuy -> NeutralView Rating Details
9/16/2015Sarasin & PartnersUpgradeBuyView Rating Details
7/13/2015Deutsche Bank AGUpgradeBuyView Rating Details
4/15/2015Societe GeneraleInitiated CoverageBuyView Rating Details
(Data available from 3/1/2015 forward)

Earnings

Earnings History for Sanofi SA (NYSE:SNY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/8/2017Q416$0.66$0.67$9.87 billion$8.88 billionViewN/AView Earnings Details
10/29/2015Q315$0.88$0.89ViewN/AView Earnings Details
4/30/2015Q115$0.61$0.73ViewN/AView Earnings Details
2/5/2015Q4$0.89$0.79ViewN/AView Earnings Details
7/31/2014Q2$0.79$0.72ViewN/AView Earnings Details
4/29/2014Q114$0.84$0.81ViewN/AView Earnings Details
2/6/2014Q4$0.88$0.93ViewN/AView Earnings Details
10/30/2013$1.01$0.93ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sanofi SA (NYSE:SNY)
Current Year EPS Consensus Estimate: $3.08 EPS
Next Year EPS Consensus Estimate: $3.28 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.65$0.72$0.69
Q2 20162$0.72$0.75$0.74
Q3 20161$0.91$0.91$0.91
Q4 20162$0.65$0.67$0.66
Q1 20171$0.75$0.75$0.75
Q2 20171$0.74$0.74$0.74
Q3 20171$0.90$0.90$0.90
Q4 20171$0.80$0.80$0.80
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Sanofi SA (NYSE:SNY)
Annual Dividend:$1.12
Dividend Yield:2.60%
Dividend Growth:-2.50% (3 Year Average)
Payout Ratio:54.90% (Based on Trailing 12 Months of Earnings)
36.36% (Based on Current Year Consensus EPS Estimate)
34.15% (Based on Next Year Consensus EPS Estimate)

Dividend History for Sanofi SA (NYSE:SNY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/17/2017annual$1.583.65%5/11/20175/15/20176/7/2017
2/22/2016Annual$1.105/5/20165/9/20166/1/2016
2/26/2015special$1.623.91%5/6/20155/8/20156/2/2015
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Sanofi SA (NYSE:SNY)
Insider Ownership Percentage: 1.00%
Institutional Ownership Percentage: 9.63%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/9/2014SanofiMajor ShareholderBuy195,000$308.27$60,112,650.00View SEC Filing  
7/8/2014SanofiMajor ShareholderBuy153,000$311.67$47,685,510.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Sanofi SA (NYSE:SNY)
DateHeadline
us.rd.yahoo.com logo8:51 am Sanofi & Regeneron (REGN (NYSE:SNY)
us.rd.yahoo.com - March 1 at 9:51 AM
thestreet.com logoAmicus CEO John Crowley, Not His Daughter Megan, Might Compel Trump to Make Big Changes at FDA (NYSE:SNY)
www.thestreet.com - March 1 at 9:51 AM
marketrealist.com logoRegeneron Expected to Witness Robust Growth in Revenues in 2017 (NYSE:SNY)
marketrealist.com - March 1 at 9:51 AM
nasdaq.com logoSanofi, Lonza In Partnership To Build Swiss Biologics Production Facility - Nasdaq (NYSE:SNY)
www.nasdaq.com - February 28 at 7:32 PM
News IconFollowing the Numbers for Sanofi SA (SNY) - BVN (NYSE:SNY)
bvnewsjournal.com - February 28 at 7:32 PM
4-traders.com logoScience Park, a member of TECOM Group & Sanofi announces partnership to .. (NYSE:SNY)
www.4-traders.com - February 28 at 11:52 AM
finance.yahoo.com logoKevzara™ (sarilumab) now available in Canada for the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis (NYSE:SNY)
finance.yahoo.com - February 28 at 11:52 AM
investopedia.com logoAmicus Therapeutics Launches Galafold in UK (NYSE:SNY)
www.investopedia.com - February 28 at 11:52 AM
marketrealist.com logoJanuvia, Vaccines May Drive Merck’s Revenue Growth in 2017 (NYSE:SNY)
marketrealist.com - February 28 at 11:52 AM
investopedia.com logoSanofi, Lonza to Build $285M Biologics Plant (NYSE:SNY)
www.investopedia.com - February 27 at 4:42 PM
4-traders.com logoSTOCKS TO WATCH : Earnings Today: Merck, Sanofi, Vesuvius (NYSE:SNY)
www.4-traders.com - February 27 at 9:10 AM
rttnews.com logoSanofi, Lonza In Partnership To Build Swiss Biologics Production Facility (NYSE:SNY)
www.rttnews.com - February 27 at 9:10 AM
finance.yahoo.com logoRegeneron and Sanofi to Present New Data on DUPIXENT® (dupilumab) for Moderate-to-Severe Atopic Dermatitis at Upcoming Medical Congresses (NYSE:SNY)
finance.yahoo.com - February 27 at 9:10 AM
finance.yahoo.com logoSanofi and Regeneron to Present New Data on Dupixent® (dupilumab) for Moderate-to-Severe Atopic Dermatitis at Upcoming Medical Congresses (NYSE:SNY)
finance.yahoo.com - February 27 at 9:10 AM
News IconNews Buzz – WisdomTree Investments, Inc. (NASDAQ:WETF), Sanofi SA (ADR) (NYSE:SNY) - Daily News Journal (press release) (NYSE:SNY)
www.journalfinance.net - February 24 at 7:40 AM
bizjournals.com logo​Ipswich consultant’s biotech training program expands into Europe (NYSE:SNY)
www.bizjournals.com - February 23 at 1:09 AM
News IconSanofi (SNY) Increases Dividend to $1.58 Per Share (NYSE:SNY)
mundoaguaysaneamiento.net - February 21 at 5:00 PM
News IconSanofi SA (SNY) Given Average Rating of "Hold" by Analysts (NYSE:SNY)
prensariotiretail.com - February 21 at 5:00 PM
marketrealist.com logoSanofi Pasteur: Why Human Vaccines Matter (NYSE:SNY)
marketrealist.com - February 21 at 5:00 PM
marketrealist.com logoWhat Happened to Sanofi’s Valuation after 4Q16? (NYSE:SNY)
marketrealist.com - February 21 at 5:00 PM
4-traders.com logoSanofi SA given €85.00 PT by Jefferies Group LLC. neutral rating. (NYSE:SNY)
www.4-traders.com - February 17 at 7:28 PM
marketrealist.com logoInside Sanofi’s Revenues in 4Q16 (NYSE:SNY)
marketrealist.com - February 17 at 7:28 PM
marketrealist.com logoRepatha Represents a Solid Growth Opportunity for Amgen in 2017 (NYSE:SNY)
marketrealist.com - February 16 at 7:42 PM
4-traders.com logoNow that Olivier Brandicourt has been caught out, would $SNY like to issue an apology to the media? $JNJ $ATLN cc @ByMadeleineA (NYSE:SNY)
www.4-traders.com - February 16 at 7:42 PM
News IconHow Sanofi blew its chance with Actelion (NYSE:SNY)
www.massdevice.com - February 16 at 7:42 PM
us.rd.yahoo.com logoAmgen Looking to Broaden Leukemia Drug Blincyto's Label (NYSE:SNY)
us.rd.yahoo.com - February 16 at 7:42 PM
marketrealist.com logoGlaxoSmithKline’s Valuation Compared to Its Peers (NYSE:SNY)
marketrealist.com - February 15 at 6:06 AM
streetinsider.com logoIpsen to Acquire Select Consumer Healthcare Products from Sanofi (SNY) for EUR83M (NYSE:SNY)
www.streetinsider.com - February 14 at 6:26 AM
investopedia.com logoSanofi Sells 5 Over-the-Counter Drugs for $88M (SNY) (NYSE:SNY)
www.investopedia.com - February 14 at 6:26 AM
investopedia.com logoSanofi to Sell 5 OTC Drugs to Ipsen for $88M (NYSE:SNY)
www.investopedia.com - February 14 at 6:26 AM
News IconShares of Sanofi (SNY) Sees Large Inflow of Net Money Flow ... - Highland Mirror (NYSE:SNY)
www.highlandmirror.com - February 13 at 8:11 AM
streetinsider.com logoIpsen to Acquire Select Consumer Healthcare Products from Sanofi (SNY) for EUR83M - StreetInsider.com (NYSE:SNY)
www.streetinsider.com - February 13 at 8:11 AM
4-traders.com logoSanofi $SNY Shares Bought by GFS Advisors LLC https://t.co/UC17cCdNnv (NYSE:SNY)
www.4-traders.com - February 11 at 3:03 AM
seekingalpha.com logoSanofi/Regeneron Praluent appeal could be decided as early as June say lawyers (NYSE:SNY)
seekingalpha.com - February 11 at 3:03 AM
capitalcube.com logoSanofi :SNY-US: Earnings Analysis: 2016 By the Numbers : February 10, 2017 (NYSE:SNY)
www.capitalcube.com - February 11 at 3:03 AM
4-traders.com logoSanofi $SNY Releases Quarterly Earnings Results, Beats Expectations By $0.01 .. (NYSE:SNY)
www.4-traders.com - February 10 at 4:26 AM
us.rd.yahoo.com logoSanofi (SNY) Q4 Earnings In Line; Can Sell Praulent for Now (NYSE:SNY)
us.rd.yahoo.com - February 10 at 4:26 AM
News IconRegeneron Pharmaceuticals Inc (REGN) And Sanofi SA (ADR) (SNY) Loses On A Suit Blocking Amgen, Inc. (AMGN) From Selling Cholesterol Drug (NYSE:SNY)
feedproxy.google.com - February 9 at 1:40 PM
feeds.benzinga.com logoRegeneron Gets 'Encouraging' Judicial Decision, Could Still Lose Appeal (NYSE:SNY)
feeds.benzinga.com - February 9 at 12:34 PM
seekingalpha.com logoSanofi Q4: Guidance Not Reassuring - Seeking Alpha (NYSE:SNY)
seekingalpha.com - February 9 at 4:56 AM
streetinsider.com logoRegeneron (REGN) and Sanofi (SNY) Confirm Stay of Permanent Injunction for Praluent (AMGN) - StreetInsider.com (NYSE:SNY)
www.streetinsider.com - February 9 at 4:56 AM
seekingalpha.com logoSanofi (SNY) Q4 2016 Results - Earnings Call Transcript - Seeking Alpha (NYSE:SNY)
seekingalpha.com - February 9 at 4:56 AM
seekingalpha.com logoSanofi Q4 sales up 3%; earnings up 137%; cash flow up 2%; shares up 2% premarket (NYSE:SNY)
seekingalpha.com - February 8 at 7:50 AM
News IconSanofi SA (ADR) (SNY) Releases Earnings Results, Beats Expectations By $0.02 EPS - Highland Mirror (NYSE:SNY)
www.highlandmirror.com - February 8 at 6:13 AM
sg.finance.yahoo.com logoSanofi meets 4Q profit forecasts (NYSE:SNY)
sg.finance.yahoo.com - February 8 at 6:13 AM
seekingalpha.com logoSanofi's Valuation Is Not Compelling (NYSE:SNY)
seekingalpha.com - February 6 at 8:03 PM
News IconResearch Reports Coverage on Drug Makers Stocks -- Sanofi, Impax Labs, Heron Therapeutics, and Biostar Pharma (NYSE:SNY)
www.kswo.com - February 6 at 8:19 AM
4-traders.com logoSanofi $SNY Position Reduced by JNBA Financial Advisors https://t.co/jmCmQvo1ad (NYSE:SNY)
www.4-traders.com - February 4 at 7:57 PM
seekingalpha.com logoFourier Love All Around As Repatha Improves Outcomes (NYSE:SNY)
seekingalpha.com - February 4 at 2:00 AM
News IconSanofi (NYSE:SNY) from Drug Manufacturers – Major – Todays Top Gains (NYSE:SNY)
twincountynews.com - February 4 at 2:00 AM

Social

What is Sanofi SA's stock symbol?

Sanofi SA trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNY."

How often does Sanofi SA pay dividends? What is the dividend yield for Sanofi SA?

Sanofi SA announced an annual dividend on Friday, February 17th. Stockholders of record on Monday, May 15th will be paid a dividend of $1.5771 per share on Wednesday, June 7th. This represents a dividend yield of 3.65%. The ex-dividend date is Thursday, May 11th. This is a positive change from Sanofi SA's previous annual dividend of $1.10.

Where is Sanofi SA's stock going? Where will Sanofi SA's stock price be in 2017?

14 analysts have issued 1 year price objectives for Sanofi SA's stock. Their forecasts range from $58.00 to $93.00. On average, they anticipate Sanofi SA's share price to reach $75.50 in the next year.

Who owns Sanofi SA stock?

Sanofi SA's stock is owned by many different of institutional and retail investors. Top institutional investors include Barrow Hanley Mewhinney & Strauss LLC (1.14%), Franklin Resources Inc. (0.82%), Hotchkis & Wiley Capital Management LLC (0.44%), FMR LLC (0.21%), Federated Investors Inc. PA (0.19%) and Senzar Asset Management LLC (0.05%).

Who sold Sanofi SA stock? Who is selling Sanofi SA stock?

Sanofi SA's stock was sold by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, Federated Investors Inc. PA, FMR LLC, Hotchkis & Wiley Capital Management LLC, Baird Financial Group Inc., Franklin Resources Inc., Envestnet Asset Management Inc. and Allianz Asset Management AG.

Who bought Sanofi SA stock? Who is buying Sanofi SA stock?

Sanofi SA's stock was acquired by a variety of institutional investors in the last quarter, including Senzar Asset Management LLC, Paulson & CO. Inc., NWQ Investment Management Company LLC, Willis Investment Counsel, First Bank & Trust, Clark Capital Management Group Inc., Russell Investments Group Ltd. and Glacier Peak Capital LLC.

How do I buy Sanofi SA stock?

Shares of Sanofi SA can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Sanofi SA stock cost?

One share of Sanofi SA stock can currently be purchased for approximately $43.13.

Sanofi SA (NYSE:SNY) Chart for Wednesday, March, 1, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Sanofi SA (NYSE:SNY)

Earnings History Chart

Earnings by Quarter for Sanofi SA (NYSE:SNY)

Dividend History Chart

Dividend Payments by Quarter for Sanofi SA (NYSE:SNY)

Last Updated on 3/1/2017 by MarketBeat.com Staff